The First Affiliated Hospital Of Zhengzhou University

This Phase 2 trial tests whether adding an extra drug (either SHR2554 or apatinib) to standard immunotherapy plus chemotherapy can help people with advanced gastric cancer who don't get enough benefit from current treatments. About 78 adults with stage III or IV stomach cancer wi…

This trial compares different fasting durations after a procedure to treat bleeding esophageal varices in people with cirrhosis. Some patients will fast for 6 hours, others for 24 or 48 hours, to see if eating earlier affects the chance of rebleeding. The study also looks at hosp…

This trial is testing whether adding an immunotherapy drug called adebrelimab to a two-drug combination of apatinib and albumin-bound paclitaxel can help people with advanced stomach or gastroesophageal junction cancer. The study enrolls adults whose cancer has progressed after f…

This study tests whether a new drug called ivoximab, when combined with the chemotherapy temozolomide, is safe and effective for people with glioma that has returned or not responded to treatment. About 29 participants will receive the combination therapy, and doctors will check …

This study compares two treatments for people with completely blocked heart arteries (chronic total occlusions). One group gets a drug-coated balloon, with or without a stent; the other gets standard stents. The goal is to see if the balloon approach keeps arteries open just as w…

This study will follow 10,000 babies born through assisted reproductive technology (ART) at a Chinese hospital to monitor their health from birth onward. Researchers will record birth weight, congenital malformations, and height development. The goal is to understand any short- a…

This real-world study is following 15,000 people with chronic hepatitis B across 200 hospitals in China. Researchers are comparing how well different antiviral drugs and interferon injections work to prevent liver cancer and improve long-term health. The goal is to find the best …